600-401-E30
p90 RSK2 Antibody
Cannot supply to this region.
- SKU:
- 600-401-E30
- Additional Names:
- p90 RSK2, Ribosomal S6 Kinase 2, RSK2, S6K-alpha 2, 90 kDa Ribosomal Protein S6 Kinase 2, MAP kinase-activated protein kinase 2a, or MAPKAPK2A|RPS6KA2
- Application:
- WB
- Physical State:
- Liquid
- Species Reactivity:
- Human
- Storage Conditions:
- Please refer to datasheet
- Supplier:
- Rockland Inc
- Host:
- Rabbit
- Reactivities:
- Human
- Buffer:
- 0.01 M HEPES, 0.15 M Sodium Chloride
- Immunogen:
- Anti-p90 RSK2 Antibody was produced by repeated immunizations with a synthetic peptide corresponding to amino acid residues from the C-terminal region.
- Formulation:
- 0.01 M HEPES, 0.15 M Sodium Chloride, pH 7.5
- Uniprot:
- Q15349
- Synonyms:
- 90 kDa ribosomal protein S6 kinase 2;HU-2;MAP kinase-activated protein kinase 1c;MAPK-activated protein kinase 1c;MAPKAPK1C;mitogen-activated protein kinase-activated protein kinase 1C;p90-RSK3;p90RSK2;pp90RSK3;ribosomal protein S6 kinase alpha-2;ribosomal protein S6 kinase, 90kDa, polypeptide 2;ribosomal S6 kinase 3;RSK;RSK3;S6K-alpha;S6K-alpha2
- Extra Details:
- p90 RSK2 Antibody detects p90 RSK2 protein. The p90 ribosomal S6 kinases (RSK)1-4 are downstream members of the extracellular signal-regulated kinase (ERK)/MAPK cascade. The loss of RSK2 activity in humans leads to Coffin-Lowry syndrome, which is characterized by mental retardation and growth deficits. Recent work suggests that RSK2 exerts a tonic regulation on G-protein coupled signaling. RSK1 is studied in cancer research and is known to inactive tumor suppressor complexes and death kinases. Anti-p90 RSK1 Antibody is ideal for investigators involved in Neuroscience, Cell Signaling, and Cancer research.
- Shipping Conditions:
- Dry Ice